載入...
Immunotherapy of Cancer
Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cy...
| 主要作者: | |
|---|---|
| 格式: | Printed Book |
| 出版: |
New Jersey.
Humana Press
2006
|
| 叢編: | Cancer drug discovery and development.
|
| 主題: |
書本目錄:
- Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches
- Current strategies for the identification of immunogenic epitopes of tumor antigens
- Current and future role of natural-killer cells in cancer immunotherapy
- The role of immune monitoring in evaluating cancer immunotherapy
- Statistical analysis of immune response assays
- DNA vaccines for cancer immunotherapy
- Dendritic cells
- Different approaches to dendritic cell-based cancer immunotherapy
- Anti-idiotype antibody vaccines for the immunotherapy of cancer
- Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics
- Tumor-reactive T-cells for adoptive immunotherapy
- T-cell adoptive immunotherapy of cancer: from translational models to clinical significance
- Retroviral-mediated gene transfer for engineering tumor-reactive T-cells
- Harnessing the potential of graft-vs-tumor
- Tumor-induced immune suppression and immune escape: mechanisms and impact on the outcome of immunotherapy of malignant disease
- The tumor microenvironment: regulation of antitumor immunity and implications for immunotherapy
- Manipulation of lymphocyte homeostasis for enhancing antitumor immunity
- Fast-lane evolution in the tumor microenvironment
- Manipulating immunological checkpoints to maximize antitumor immunity
- Interleukin-2 as cancer therapy
- Biological and clinical properties of the type 1 interferons
- Promising g [gamma]-chain cytokines for cancer immunotherapy: interleukins-7, -15, and -21 as vaccine adjuvants, growth factors
- The therapeutic use of natural-killer cells in hematological malignancies
- Antibody therapy for solid tumors
- Antibody therapy for non-Hodgkin's lymphoma
- Approaches to in vivo imaging of cancer immunotherapy
- Design issues for early-stage clinical trials for cancer vaccines
- Monoclonal antibody therapy for cancer.